Phase 1 Study Of Tg-1701, A Selective Irreversible Inhibitor Of Bruton'S Tyrosine Kinase (Btk), In Patients With Relapsed/Refractory B-Cell Malignancies

BLOOD(2019)

Cited 5|Views2
No score
Abstract
Introduction
More
Translated text
Key words
BTK Inhibitors,Transition State Analogue Inhibitors
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined